Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Fresh Tracks Therapeutics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(655)
•••
Post by TimeBuilderon May 11, 2023 9:22am
192 Views
Post# 35442787

FYI: Rating updates copied from TDWBDI ;>))

FYI: Rating updates copied from TDWBDI ;>))

Worth repeating  IMO
Ratings change for May 07, 2023 - May 13, 2023


Date
Symbol
Brokerage
Analyst Name
Analyst Ranking out of 8,370
Current Rating
Current Target
11 May 2023
BIR
Raymond James
Jeremy Mccrea
196
BUY
$11.00
11 May 2023
PIPE
RBC Capital
Luke Davis
90
BUY
$3.75
10 May 2023
CRRX
Stifel Nicolaus
Justin Keywood
2,730
BUY
$4.25
10 May 2023
BTO
BMO Capital
Brian Quast
1,004
BUY
$10.03
09 May 2023
CRRX
Echelon Wealth Partners
Stefan Quenneville
7,726
BUY
$5.25
09 May 2023
NPI
BMO Capital
Benjamin Pham
251
BUY
$60.20
09 May 2023
ALA
Credit Suisse
Andrew Kuske
2,052
BUY
$32.50
09 May 2023
BMO
Barclays
Unknown Analyst
0
BUY
$127.00
09 May 2023
BNS
Barclays
Unknown Analyst
0
SELL
$64.00
09 May 2023
RY
Barclays
Unknown Analyst
0
SELL
$124.00
09 May 2023
TD
Barclays
Unknown Analyst
0
HOLD
$83.00
08 May 2023
BDI
Canaccord Genuity
Matthew Lee
1,502
BUY
$8.25
08 May 2023
ARX
National Bank
Travis Wood
34
BUY
$23.00
08 May 2023
TD
Bank of America Securities
Ebrahim Poonawala
5,839
BUY
$97.65
08 May 2023
T
Bank of America Securities
David Barden
4,549
BUY
$34.78
08 May 2023
T
Barclays
Kannan Venkateshwar
1,218
HOLD
$28.09
08 May 2023
PPL
Barclays
Anthony Linton
1,098
HOLD
$49.00
07 May 2023
ARX
Barclays
Unknown Analyst
0
BUY
$22.00

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities